CHICAGO, April 30, 2024 /PRNewswire/ -- Dental Bone Graft Substitutes Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029 according to a new report by MarketsandMarkets™.

MarketsandMarkets Logo

The global population is growing older, leading to an increased demand for dental bone graft substitute also the increasing popularity of dental implants as a tooth replacement option creates a direct need for bone graft substitutes which is expected to drive the market growth. However, high material costs and surgical costs associated with hospital or clinic fees, surgeon fees, and anesthesia is expected to challenge the growth of the market.

This report divides dental bone graft substitute into four segments – type, application, mechanism, product, end user and region.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690

Browse in-depth TOC on "Dental Bone Graft Substitutes Market"
260 - Tables
50 - Figures
400 - Pages

Dental Bone Graft Substitutes Market Scope:

Report Coverage

Details

Market Revenue in 2024

$1.3 billion

Estimated Value by 2029

$1.8 billion

Growth Rate

Poised to grow at a CAGR of 7.7%

Market Size Available for

2022–2029

Forecast Period

2024–2029

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Dental bone graft substitute – Type, Application, Mechanism, Product, End User and Region.

Geographies Covered

Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growing Prevalence of Dental Disorders

Key Market Drivers

Rising aging population

"Based on dental bone graft substitute by end user, the hospitals segment is expected to grow at the highest CAGR during the forecast period."

Under end user, hospital segment is forecasted to grow at the highest CAGR from 2024 to 2029., Bone grafting is frequently used in hospitals for oral and maxillofacial surgery for procedures like jaw reconstruction, alveolar ridge preservation, cleft lip and palate repair and dental implantology, when natural jawbone is insufficient for implant placement, bone grafts provide a foundation for successful implant osseointegration (fusion with bone).

"The Bio-Oss segment is expected to account for the largest share, by product in dental bone graft substitute."

By product segment, dental bone graft substitute is segmented into Bio-Oss, osteograf, grafton and others. Bio-Oss accounts for the largest share in by product category. Bio-Oss has a long history of successful use in dental bone grafting procedures, with extensive clinical research supporting its efficacy and safety which is expected to drive the segment growth.

"The osteoconduction segment is expected to account for the largest share, by mechanism in dental bone graft substitute."

By mechanism segment, dental bone graft substitute is segmented into bio osteoconduction, osteoinduction, osteopromotion, osteogenesis. osteoconduction accounts for the largest share in by mechanism category. Osteoconduction promotes bone regeneration at the defect site, provides a foundation for dental implant placement and supports jawbone structure and prevents collapse which is expected to drive the segment growth.

"In 2023, Europe was the region with the second largest market share in dental bone graft substitute. "

Dental bone graft substitute is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries.

Europe accounted for the second-largest share of dental bone graft substitute in 2023. The apidly aging population, leading to a higher demand for dental bone graft substitute is driving the growth of dental bone graft substitute in the European region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

Dental Bone Graft Substitutes Market Dynamics:

Drivers:

  1. Rising aging population

Restraints:

  1. Stringent regulatory guidelines for medical devices

Opportunities:

  1. Growing Prevalence of Dental Disorders

Challenge:

  1. High Surgical Procedures Costs

Key Market Players of Dental Bone Graft Substitutes Industry:

Key players in dental bone graft substitute include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland),  Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and  Arora Biosurgery Ltd. (New Zealand).

A breakdown of the primary participants (supply-side) for the dental bone graft substitute market referred to for this report is provided below:

  • By Company Type: Tier 40%, Tier 35%, and Tier 25%
  • By Designation: C-level–30%, Director Level–55%, and Others–15%
  • By Region: North America–20%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East & Africa-30%.

Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159678690

Recent Developments of Dental Bone Graft Substitutes Industry:

  • In April 2023, Henry Schein acquired a majority ownership position in Biotech Dental, aiming to create a digital workflow that provides a seamless journey for customers to increase case acceptance and improve clinical outcomes for practitioners.
  • In March 2022, Dentsply Sirona Inc. partnered with Platform for Better Oral Health in Europe. The goal is to improve oral health and the prevention of oral diseases - as well as address oral health inequalities and challenges.
  • In February 2022, Envista Holdings Corporation (US) partnered with Vitaldent Group (Spain). This extended agreement positions Envista as the preferred supplier of implants (Nobel Biocare) and clear aligners (Spark).
  • In January 2022, Johnson & Johnson partnered with Microsoft Corporation, Inc. The Johnson & Johnson Medical Devices Companies (JJMDC) collaborated with Microsoft Corporation Inc, (US) to enable and expand JJMDC's secure and compliant digital surgery ecosystem.

Dental Bone Graft Substitutes Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental bone graft substitute market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and the subsequent increase in tooth repair procedures, changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising do activity, growing demand for bone graft substitutes from emerging markets) and challenges (pricing pressure faced by prominent market players)
  • Market Penetration: It includes extensive information on product portfolios offered by the major players in the global dental bone graft substitute market. The report includes various segments in market type, application, mechanism, product, end user and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitute market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets type, application, mechanism, product, end user and region
  • Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global dental bone graft substitute market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global dental bone graft substitute market.

Related Reports:

Dental Implants and Prosthetics Market - Global Forecasts to 2029

Biomaterials Market - Global Forecasts to 2029

Restorative Dentistry Market - Global Forecasts to 2028

Medical Ceramics Market - Global Forecasts to 2027

Dental Consumables Market - Global Forecasts to 2027

Get access to the latest updates on Dental Bone Graft Substitutes Companies and Dental Bone Graft Substitutes Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/dental-bone-graft-substitutes-market-worth-1-8-billion--marketsandmarkets-302131562.html

SOURCE MarketsandMarkets

Copyright 2024 PR Newswire